JRCT ID: jRCT1060220019
Registered date:25/05/2022
Detectability of EOB-MRI for pancreatic liver metastases after neoadjuvant chemotherapy
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Pancreatic cancer |
| Date of first enrollment | 25/05/2022 |
| Target sample size | 211 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | sensitivity of EOB-MRI for liver metastasis after Neoadjuvant chemotherapy |
|---|---|
| Secondary Outcome | specificity, accuracy, positive predictive value,negative predictive value of EOB-MRI for liver metastasis after Neoadjuvant chemotherapy risk factor for liver metastasis after Neoadjuvant chemotherapy |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Pancreatic cancer undergoing Neoadjuvant chemotherapy Resectable and Borderline resectable pancreatic cancer |
| Exclude criteria | Contraindications for contrast enhanced CT or EOB-MRI Performance status 2,3,4 younger than 20 years old patients |
Related Information
| Primary Sponsor | Fujii Yuki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Yuki Fujii |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama-city, Okayama Okayama Japan 700-855 |
| Telephone | +81-86-235-7219 |
| y_f1105@yahoo.co.jp | |
| Affiliation | Department of Gastroenterology and Hepatology |
| Scientific contact | |
| Name | Yuki Fujii |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama-city, Okayama Okayama Japan 700-8558 |
| Telephone | +81-86-225-5991 |
| y_f1105@yahoo.co.jp | |
| Affiliation | Department of Gastroenterology and Hepatology |